OPA1 rs121912502: Understanding the Arg445His Variant
The rs121912502 variant in the OPA1 gene involves a specific missense alteration known as Arg445His. This genetic change is associated with autosomal dominant optic atrophy type 1, a condition characterized by progressive vision loss due to the degeneration of retinal ganglion cells.
What each genotype means
Typical OPA1 profile
This genotype represents the common, non-altered sequence for this position in the OPA1 gene. It is not associated with the specific Arg445His alteration linked to autosomal dominant optic atrophy type 1.
This is the most common genotype found in the general population.
Arg445His variant carrier
This genotype indicates the presence of the Arg445His missense alteration in the OPA1 gene. Research associates this specific change with autosomal dominant optic atrophy type 1, a condition characterized by progressive vision loss, though clinical expression can be variable and incomplete. Please discuss these findings with a genetic counselor or ophthalmologist to understand the implications for your health.
This genotype is extremely rare in the general population, with a frequency significantly below 0.0001 in public control databases.
Homozygous Arg445His variant
This genotype indicates that both copies of the OPA1 gene carry the Arg445His alteration. While OPA1-related optic atrophy is typically inherited in an autosomal dominant pattern, the presence of this variant on both alleles is exceptionally rare and warrants professional clinical evaluation. Consult with a medical geneticist to discuss the potential impact on your vision and health.
This genotype is not observed in standard population control databases and is considered extremely rare.
What is rs121912502?
The rs121912502 variant is a specific change in the DNA sequence of the OPA1 gene. In genetic terms, this is a missense mutation, meaning it results in a single amino acid substitution—specifically, the replacement of arginine with histidine at position 445 of the OPA1 protein. This variant is located within the OPA1 gene, which provides instructions for creating a protein essential for mitochondrial function. Because this variant is extremely rare in the general population, it is primarily studied in the context of clinical cases where individuals present with specific symptoms of optic neuropathy. Understanding such variants helps researchers map the relationship between specific DNA changes and their downstream effects on cellular health, particularly in tissues with high energy demands like the optic nerve.
The Role of the OPA1 Gene
The OPA1 gene encodes a protein that resides in the inner mitochondrial membrane. This protein is a member of the dynamin-related GTPase superfamily and plays a critical role in maintaining mitochondrial dynamics, including the fusion of mitochondrial membranes and the maintenance of mitochondrial DNA. By regulating the structure of mitochondrial cristae—the internal folds of the mitochondria—the OPA1 protein helps ensure efficient energy production and protects cells from programmed cell death, or apoptosis. When the OPA1 protein is dysfunctional, mitochondria may become fragmented, leading to impaired cellular energy metabolism. This dysfunction is particularly detrimental to retinal ganglion cells, which are highly sensitive to mitochondrial health. The loss of these cells is the primary driver of the visual impairment observed in conditions associated with OPA1 mutations.
Research and Clinical Associations
Research associates the rs121912502 variant with autosomal dominant optic atrophy type 1 (ADOA). ADOA is a hereditary optic neuropathy that typically manifests in childhood or early adulthood as bilateral, progressive vision loss. The evidence linking this specific variant to the condition is categorized as limited, reflecting the rarity of the mutation in clinical databases. In many cases of ADOA, the disease mechanism is thought to be haploinsufficiency, where one functional copy of the gene is insufficient to maintain normal cellular function. However, missense variants like Arg445His may also exert dominant-negative effects, where the altered protein interferes with the function of the normal protein produced by the other allele. Because the clinical presentation of OPA1-related disorders can be highly variable, researchers continue to investigate how specific variants influence the severity and age of onset of visual symptoms.
Population Frequency
The rs121912502 variant is extremely rare in public control databases, with a minor allele frequency (MAF) reported as less than 0.0001. This low frequency indicates that the variant is not a common polymorphism found in the general population but is instead a rare genetic alteration often identified in clinical settings.
Navigating Genetic Information
Information regarding rare genetic variants like rs121912502 is primarily intended for research and clinical understanding. If you have received genetic testing results indicating the presence of this variant, it is important to consult with a qualified healthcare professional, such as a genetic counselor or an ophthalmologist specializing in neuro-ophthalmology. They can provide context based on your personal and family medical history. It is important to remember that the presence of a genetic variant does not always guarantee the development of a specific condition, as factors like penetrance and expressivity can vary. Never use genetic information to self-diagnose or make medical decisions without professional guidance. Clinical management for optic atrophy is evolving, and discussions with a clinician can help you understand current supportive care options or potential participation in clinical research.
How common is this variant?
The rs121912502 variant is extremely rare in public control databases, with a minor allele frequency (MAF) reported as less than 0.0001.
Frequently asked questions
What is autosomal dominant optic atrophy?
Autosomal dominant optic atrophy is an inherited condition that causes the progressive loss of retinal ganglion cells, leading to vision impairment. It is most commonly caused by mutations in the OPA1 gene.
Is rs121912502 a common genetic variant?
No, rs121912502 is extremely rare in the general population. It is not considered a common polymorphism.
Can OPA1-related vision loss be treated?
Currently, there is no cure for OPA1-related optic atrophy, but research into treatments like idebenone and gene therapy is ongoing. Patients should discuss management options with an ophthalmologist.
What should I do if I have this variant?
If you have this variant, you should consult with a genetic counselor or a medical specialist. They can help interpret the results in the context of your health and family history.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121912502?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29